| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT05898620 | A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome | RECRUITING | PHASE1, PHASE2 | 2023-06-13 | 2029-10 | 2029-10 |
| NCT05228145 | Gene Therapy Study for Children With CLN5 Batten Disease | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2022-01-31 | 2028-11 | 2028-11 |
| NCT04659629 | NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer | COMPLETED | PHASE1 | 2021-04-26 | 2024-08-15 | 2022-12-15 |